Literature DB >> 18193116

PCR-based assessment of the recovery rate of exfoliated colonocytes or cancer cells from fecal samples depends on the storage conditions after defecation.

Shigeki Onouchi1, Hisayuki Matsushita, Sayuri Nomura, Takashi Minowa, Yasuhiro Matsumura.   

Abstract

BACKGROUND AND AIMS: We recently developed a new methodology for isolating colonocytes from fecal samples. We then applied a DNA-based analysis to the isolated colonocytes to detect colorectal cancer cells originating from any part of the colorectum. The purpose of the present study was to determine how long after defecation and at what temperature the fecal samples should be stored to isolate the colonocytes successfully.
METHODS: Fecal samples were collected from 6 patients with colorectal cancer and 6 healthy volunteers soon after defecation at the National Cancer Center Hospital. The fecal samples were stored at 4 degrees C, room temperature or 40 degrees C for 0, 24 or 48 hours. Colonocytes were then isolated from the fecal samples, and the DNA was purified. Finally, PCR for p53, K-ras and APC was conducted to determine whether the corresponding PCR products could be obtained.
RESULTS: The colonocyte recovery rate was not reduced, when compared with the data for successful PCR amplification, if the fecal samples were kept at 4 degrees C after defecation and if the colonocytes were isolated within 48 hours after defecation.
CONCLUSIONS: The present data provided important clinical knowledge regarding the storage of fecal samples for future mass screening tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18193116

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  1 in total

1.  Improved recovery of exfoliated colonocytes from feces using newly developed immunomagnetic beads.

Authors:  Yoshikatsu Koga; Masahiro Yasunaga; Satoshi Katayose; Yoshihiro Moriya; Takayuki Akasu; Shin Fujita; Seiichiro Yamamoto; Hideo Baba; Yasuhiro Matsumura
Journal:  Gastroenterol Res Pract       Date:  2008-12-22       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.